中高疾病活动度增加早期类风湿关节炎亚临床动脉粥样硬化进展风险:一项5年前瞻性研究
该5年前瞻性研究纳入104例无明确心血管疾病的连续早期类风湿关节炎患者,接受1年紧密控制治疗后按标准诊疗管理,基线及第5年行高分辨率颈动脉超声。持续中高疾病活动度(ca-DAS28-ESR>3.2)者亚临床动脉粥样硬化进展风险显著高于持续缓解者(OR 5.05,95%CI 1.53,16.64,p=0.008),持续低疾病活动度与缓解者风险相似。
要点
- 104例早期类风湿关节炎患者中42例(40.4%)出现亚临床动脉粥样硬化进展。
- 持续中高疾病活动度者亚临床动脉粥样硬化进展风险为持续缓解者的OR 5.05(95%CI 1.53,16.64,p=0.008)。
- 持续低疾病活动度与持续缓解者的亚临床动脉粥样硬化进展风险相似。
核心结论
- 达到持续低疾病活动度或缓解可能预防早期类风湿关节炎患者的动脉粥样硬化进展。
- 以持续低疾病活动度或缓解为目标的达标治疗策略可能通过预防亚临床动脉粥样硬化进展降低心血管疾病风险。
研究设计与样本
- 5年前瞻性研究,纳入104例无明确心血管疾病的连续早期类风湿关节炎患者(年龄52±11岁,81例(77.9%)女性)。
- 患者接受1年紧密控制治疗,随后按标准诊疗管理。
- 基线和第5年行高分辨率颈动脉超声评估。
- 以随访期间累积平均DAS28-ESR(ca-DAS28-ESR)代表炎症负荷,持续低疾病活动度或缓解定义为ca-DAS28-ESR≤3.2。
- 主要结局为亚临床动脉粥样硬化进展(AP+),定义为第5年出现新发斑块、斑块区域增大和/或颈动脉最大内膜中层厚度进展≥0.9 mm。
主要发现
- 52例(50%)患者达到持续低疾病活动度或缓解,42例(40.4%)出现AP+。
- AP+组患者年龄更大且基线传统心血管危险因素更多。
- 多因素logistic回归显示,持续中高疾病活动度(ca-DAS28-ESR>3.2)者AP+风险显著高于持续缓解者(OR 5.05,95%CI 1.53,16.64,p=0.008)。
- 达到持续低疾病活动度与持续缓解者的AP+风险相似。
关键数值与推荐
- 持续低疾病活动度或缓解状态定义为ca-DAS28-ESR≤3.2。
- AP+定义为第5年出现新发斑块、斑块区域增大和/或颈动脉最大内膜中层厚度进展≥0.9 mm。
- 持续中高疾病活动度(ca-DAS28-ESR>3.2)者AP+风险为持续缓解者的OR 5.05(95%CI 1.53,16.64,p=0.008)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To elucidate the association between different disease activity levels over time on long-term vascular outcomes in patients with early rheumatoid arthritis (ERA). METHODS: This was a 5-year prospective study. Patients with consecutive ERA without overt cardiovascular disease (CVD) were recruited to receive 1 year of tight-control treatment followed by standard-of-care management. High-resolution carotid ultrasound was assessed at baseline and year 5. The primary outcome was subclinical atherosclerosis progression (AP+), defined as the occurrence of incident plaque, increased region harbouring plaques and/or maximum carotid intima-media thickness progression ≥0.9 mm at year 5. Inflammatory burden during the follow-up period was represented by the cumulative average Disease Activity Score 28-erythrocyte sedimentation rate (ca-DAS28-ESR). Persistent low disease activity (LDA) or remission state was defined as ca-DAS28-ESR≤3.2. RESULTS: One-hundred and four patients with ERA (age: 52±11 years, 81 (77.9%) female) were included in this analysis. Fifty-two (50%) patients achieved persistent LDA or remission and 42 patients (40.4%) had AP+. Patients in the AP+ group were older and had more traditional cardiovascular risk factors at baseline. Multivariate logistic regression analysis revealed that patients with persistent moderate or high disease activity (ca-DAS28-ESR>3.2) had a significantly increased risk of AP+ (OR 5.05, 95% CI 1.53, 16.64, p=0.008) compared with those who achieved persistent remission. The risk of AP+ was similar in patients who achieved persistent LDA and remission. CONCLUSIONS: Achieving persistent LDA or remission may prevent progression of atherosclerosis in ERA. A treat-to-target approach aiming at sustained LDA or remission may reduce the risk of CVD by preventing AP+.
引用
- Meng H, Cheng IT, Yan BPY, et al. Moderate and high disease activity levels increase the risk of subclinical atherosclerosis progression in early rheumatoid arthritis: a 5-year prospective study. RMD Open. 2024. PMID: 38199848. doi:10.1136/rmdopen-2023-003488
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。